Total
0
Shares
StageZero Life Sciences expands COVID-19 test range
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Datametrex AI Limited (DM) has implemented a COVID-19 testing program for all employees and consultants
  • The company is implementing both rapid testing and lab-based polymerase chain reaction testing
  • These tests can detect the new variants
  • Datametrex AI Limited is a technology-focused company
  • Datametrex AI Limited opened trading at C$0.24 per share

Datametrex AI Limited (DM) has implemented an internal COVID-19 testing program.

This preventative program is for all the company employees, consultants, technicians, nurses, and lab partner employees.

Datametrex is implementing this testing protocol with both rapid testing and traditional lab-based polymerase chain reaction (PCR) testing.

The manufacturers have confirmed that these tests can detect the new variants.

With the increase in transmissible occurring with both the Brazil and UK variants, management felt it was prudent to increase the levels of testing to keep individuals in the company and community safe from contracting and inadvertently spreading the coronavirus.

Everyone in the company has also received training to monitor compliance to stop the spread of the coronavirus by wearing masks and including 2+2 movement restriction by keeping a distance of 2 metres from others whenever possible.

The testing will be managed by the company's own trained nurses and processed by their lab partner technicians.

"The new Brazil and UK variants are highly contagious and spreading, management felt a significant need to improve the frequency and level of participation in providing COVID-19 testing for everyone in and around the company as part of the answer to keep people safe," said Marshall Gunter, Chief Executive Officer, Datametrex AI Limited.

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.

Datametrex AI Limited opened trading at C$0.24 per share.

More From The Market Herald
Leveljump (TSXV:JUMP) to acquire Ontario clinics

" Leveljump (TSXV:JUMP) to acquire Ontario clinics

Leveljump Healthcare (JUMP) is set to acquire three Ontario diagnostic imaging clinics from a private vendor.
CloudMD (TSXV:DOC) announces a change of auditors and new board of director nominees

" CloudMD (TSXV:DOC) announces a change of auditors and new board of director nominees

CloudMD has nominated Duncan Hannay and Karen Adams to the company’s board of directors.
Psyence Group (CSE:PSYG) and Pure Extracts (CSE:PULL) form psychedelics joint venture

" Psyence Group (CSE:PSYG) and Pure Extracts (CSE:PULL) form psychedelics joint venture

Pure Extracts (PULL) and Psyence Group (PSYG) have formed a JV for psychedelic medicinal mushroom extracts.
PharmaDrug (CSE:PHRX) announces meeting with FDA

" PharmaDrug (CSE:PHRX) announces meeting with FDA

PharmaDrug (PHRX) has been granted a pre-investigational new drug meeting with the FDA for its COVID-19 treatment.